Because of the potential risk of fetal harm, pregnant women should not receive Taxotere(R). Women of childbearing potential should avoid becoming pregnant during treatment with Taxotere(R).
Before receiving Taxotere(R), tell your doctor if -- You have any allergies -- You are taking any other medicines - including nonprescription (over- the-counter) drugs, vitamins, and dietary or herbal supplements When taking Taxotere(R), contact your doctor if -- You have symptoms of an allergic reaction (warm sensation, tightness in your chest, itching/hives, or shortness of breath) -- You experience any other side effects
For full prescribing information, including boxed WARNING, call 800-633-1610 or visit http://www.taxotere.com.
Sanofi-aventis is one of the world leaders in the pharmaceutical industry, ranking number one in Europe. Backed by a world-class R&D organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine and vaccines. Sanofi-aventis is listed in Paris and in New York .
Forward Looking Statements
This press release contains forward-looking statements as
defined in the Private Securities Litigation Reform Act of 1995, as
amended. Forward-looking statements are statements that are not
historical facts. These statements include financial projections
and estimates and their underlying assumptions, statements
regarding plans, objectives, intentions and expectations with
respect to future events, operations, products and services, and